Identification of 14-3-3β Gene as a novel miR-152 target using a proteome-based approach

Journal of Biological Chemistry

Volumn 289, Issue 45, 2014, Pages 31121-31135

  Jasinski Bergner, Simon ^a   Stehle, Franziska ^a   Gonschorek, Evamaria ^a   Kalich, Jana ^a   Schulz, Kristin ^a   Huettelmaier, Stefan ^a   Braun, Juliane ^a   Seliger, Barbara ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA G ANTIGEN; MICRORNA; MICRORNA 152; PACLITAXEL; PROTEIN 14 3 3; PROTEIN 14 3 3 BETA; PROTEIN BAX; PROTEIN BCL 2; UNCLASSIFIED DRUG; HLA C ANTIGEN; MIRN152 MICRORNA, HUMAN; PROTEOME; YWHAB PROTEIN, HUMAN;

14 3 3 BETA GENE; 3' UNTRANSLATED REGION; APOPTOSIS; ARTICLE; BCL2 GENE; CANCER INHIBITION; CONTROLLED STUDY; DNA MICROARRAY; DOWN REGULATION; GENE EXPRESSION; GLIOMA; HUMAN; HUMAN CELL; LUNG CANCER; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NEUROBLASTOMA; OSTEOSARCOMA; OVERALL SURVIVAL; PROTEIN EXPRESSION; PROTEOMICS; TWO DIMENSIONAL GEL ELECTROPHORESIS; UPREGULATION; CELL PROLIFERATION; CELL SURVIVAL; CHEMISTRY; GENE EXPRESSION REGULATION; HEK293 CELL LINE; MASS SPECTROMETRY; METABOLISM; NEOPLASM; PROCEDURES; T LYMPHOCYTE; TUMOR CELL LINE;

14-3-3 PROTEINS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; CELL SURVIVAL; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HLA-C ANTIGENS; HLA-G ANTIGENS; HUMANS; MASS SPECTROMETRY; MICRORNAS; NEOPLASMS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PACLITAXEL; PROTEOME; PROTEOMICS; T-LYMPHOCYTES;

EID: 84910027208     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M114.556290     Document Type: Article

References (53)

1. Berezikov, E. (2011) Evolution of microRNA diversity and regulation in animals. Nat. Rev. Genet. 12, 846-860
2. Kozomara, A., and Griffiths-Jones, S. (2011) miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res. 39, D152-D157
3. Grimson, A., Farh, K. K., Johnston, W. K., Garrett-Engele, P., Lim, L. P., and Bartel, D. P. (2007) MicroRNA targeting specificity in mammals: determinants beyond seed pairing. Mol. Cell 27, 91-105
4. Manaster, I., Goldman-Wohl, D., Greenfield, C., Nachmani, D., Tsukerman, P., Hamani, Y., Yagel, S., and Mandelboim, O. (2012) miRNA-mediated control of HLA-G expression and function. PLoS ONE 7, e33395
5. Amiot, L., Ferrone, S., Grosse-Wilde, H., and Seliger, B. (2011) Biology of HLA-G in cancer: a candidate molecule for therapeutic intervention? Cell. Mol. Life Sci. 68, 417-431
6. Bukur, J., Jasinski, S., and Seliger, B. (2012) The role of classical and nonclassical HLA class I antigens in human tumors. Semin. Cancer Biol. 22, 350-358
7. Dunker, K., Schlaf, G., Bukur, J., Altermann, W. W., Handke, D., and Seliger, B. (2008) Expression and regulation of non-classical HLA-G in renal cell carcinoma. Tissue Antigens 72, 137-148
8. Kulkarni, S., Savan, R., Qi, Y., Gao, X., Yuki, Y., Bass, S. E., Martin, M. P., Hunt, P., Deeks, S. G., Telenti, A., Pereyra, F., Goldstein, D., Wolinsky, S., Walker, B., Young, H. A., and Carrington, M. (2011) Differential microRNA regulation of HLA-C expression and its association with HIV control. Nature 472, 495-498
9. Almeida, C. R., Ashkenazi, A., Shahaf, G., Kaplan, D., Davis, D. M., and Mehr, R. (2011) HumanNKcells differ more in their KIR2DL1-dependent thresholds for HLA-Cw6-mediated inhibition than in their maximal killing capacity. PLoS ONE 6, e24927
10. Almeida, C. R., and Davis, D. M. (2006) Segregation of HLA-C from ICAM-1 at NK cell immune synapses is controlled by its cell surface density. J. Immunol. 177, 6904-6910
11. Liu, T. A., Jan, Y. J., Ko, B. S., Chen, S. C., Liang, S. M., Hung, Y. L., Hsu, C., Shen, T. L., Lee, Y. M., Chen, P. F., Wang, J., Shyue, S. K., and Liou, J. Y. (2011) Increased expression of 14-3-3β promotes tumor progression and predicts extrahepatic metastasis and worse survival in hepatocellular carcinoma. Am. J. Pathol. 179, 2698-2708
12. Tsuruta, T., Kozaki, K., Uesugi, A., Furuta, M., Hirasawa, A., Imoto, I., Susumu, N., Aoki, D., and Inazawa, J. (2011) miR-152 is a tumor suppressor microRNA that is silenced by DNA hypermethylation in endometrial cancer. Cancer Res. 71, 6450-6462
13. Xiang, Y., Ma, N., Wang, D., Zhang, Y., Zhou, J., Wu, G., Zhao, R., Huang, H., Wang, X., Qiao, Y., Li, F., Han, D., Wang, L., Zhang, G., and Gao, X. (2014) miR-152 and miR-185 co-contribute to ovarian cancer cells cisplatin sensitivity by targeting DNMT1 directly: a novel epigenetic therapy independent of decitabine. Oncogene 33, 378-386
14. Zhu, C., Li, J., Ding, Q., Cheng, G., Zhou, H., Tao, L., Cai, H., Li, P., Cao, Q., Ju, X., Meng, X., Qin, C., Hua, L., Shao, P., and Yin, C. (2013) miR-152 controls migration and invasive potential by targeting TGFin prostate cancer cell lines. Prostate 73, 1082-1089
15. Sanfiorenzo, C., Ilie, M. I., Belaid, A., Barlési, F., Mouroux, J., Marquette, C. H., Brest, P., and Hofman, P. (2013) Two panels of plasma microRNAs as non-invasive biomarkers for prediction of recurrence in resectable NSCLC. PLoS ONE 8, e54596
16. Zhu, X. M., Han, T., Wang, X. H., Li, Y. H., Yang, H. G., Luo, Y. N., Yin, G. W., and Yao, Y. Q. (2010) Overexpression of miR-152 leads to reduced expression of human leukocyte antigen-G and increased natural killer cell mediated cytolysis in JEG-3 cells. Am. J. Obstet. Gynecol. 202, 592.e591-597
17. Bukur, J., Rebmann, V., Grosse-Wilde, H., Luboldt, H., Ruebben, H., Drexler, I., Sutter, G., Huber, C., and Seliger, B. (2003) Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res. 63, 4107-4111
18. Herrmann, F., Trowsdale, J., Huber, C., and Seliger, B. (2003) Cloning and functional analyses of the mouse tapasin promoter. Immunogenetics 55, 379-388
19. Lichtenfels, R., Ackermann, A., Kellner, R., and Seliger, B. (2001) Mapping and expression pattern analysis of key components of the major histocompatibility complex class I antigen processing and presentation pathway in a representative human renal cell carcinoma cell line. Electrophoresis 22, 1801-1809
20. Seliger, B., Fedorushchenko, A., Brenner, W., Ackermann, A., Atkins, D., Hanash, S., and Lichtenfels, R. (2007) Ubiquitin COOH-terminal hydrolase 1: a biomarker of renal cell carcinoma associated with enhanced tumor cell proliferation and migration. Clin. Cancer Res. 13, 27-37
21. Chen, C., Ridzon, D. A., Broomer, A. J., Zhou, Z., Lee, D. H., Nguyen, J. T., Barbisin, M., Xu, N. L., Mahuvakar, V. R., Andersen, M. R., Lao, K. Q., Livak, K. J., and Guegler, K. J. (2005) Real-time quantification of micro- RNAs by stem-loop RT-PCR. Nucleic Acids Res. 33, e179
22. Varkonyi-Gasic, E., Wu, R., Wood, M., Walton, E. F., and Hellens, R. P. (2007) Protocol: a highly sensitive RT-PCR method for detection and quantification of microRNAs. Plant Methods 3, 12
23. Bukur, J., Herrmann, F., Handke, D., Recktenwald, C., and Seliger, B. (2010) Identification of E2F1 as an important transcription factor for the regulation of tapasin expression. J. Biol. Chem. 285, 30419-30426
24. Stehle, F., Schulz, K., Fahldieck, C., Kalich, J., Lichtenfels, R., Riemann, D., and Seliger, B. (2013) Reduced immunosuppressive properties of axitinib in comparison with other tyrosine kinase inhibitors. J. Biol. Chem. 288, 16334-16347
25. Haraguchi, T., Ozaki, Y., and Iba, H. (2009) Vectors expressing efficient RNA decoys achieve the long-term suppression of specific microRNA activity in mammalian cells. Nucleic Acids Res. 37, e43
26. Braun, J., Misiak, D., Busch, B., Krohn, K., and Hüttelmaier, S. (2014) Rapid identification of regulatory microRNAs by miTRAP (miRNA trapping by RNA in vitro affinity purification). Nucleic Acids Res. 42, e66
27. Köhn, M., Lederer, M., Wächter, K., and Hüttelmaier, S. (2010) Nearinfrared (NIR) dye-labeled RNAs identify binding of ZBP1 to the noncoding Y3-RNA. RNA 16, 1420-1428
28. Candiano, G., Bruschi, M., Musante, L., Santucci, L., Ghiggeri, G. M., Carnemolla, B., Orecchia, P., Zardi, L., and Righetti, P. G. (2004) Blue silver: a very sensitive colloidal Coomassie G-250 staining for proteome analysis. Electrophoresis 25, 1327-1333
29. Zeeberg, B. R., Feng, W., Wang, G., Wang, M. D., Fojo, A. T., Sunshine, M., Narasimhan, S., Kane, D. W., Reinhold, W. C., Lababidi, S., Bussey, K. J., Riss, J., Barrett, J. C., and Weinstein, J. N. (2003) GoMiner: a resource for biological interpretation of genomic and proteomic data. Genome Biol. 4, R28
30. Takihara, Y., Matsuda, Y., and Hara, J. (2000) Role of the β isoform of 14-3-3 proteins in cellular proliferation and oncogenic transformation. Carcinogenesis 21, 2073-2077
31. 2/M progression. Mol. Cell 1, 3-11
32. Urano, T., Saito, T., Tsukui, T., Fujita, M., Hosoi, T., Muramatsu, M., Ouchi, Y., and Inoue, S. (2002) Efp targets 14-3-3 sigma for proteolysis and promotes breast tumour growth. Nature 417, 871-875
33. Dweep, H., Sticht, C., Pandey, P., and Gretz, N. (2011) miRWalk-database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J. Biomed. Inform. 44, 839-847
34. Krüger, J., and Rehmsmeier, M. (2006) RNAhybrid: microRNA target prediction easy, fast and flexible. Nucleic Acids Res. 34, W451-W454
35. Lewis, B. P., Burge, C. B., and Bartel, D. P. (2005) Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120, 15-20
36. Wang, X. (2008) miRDB: a microRNA target prediction and functional annotation database with a wiki interface. RNA 14, 1012-1017
37. Song, Y. X., Yue, Z. Y., Wang, Z. N., Xu, Y. Y., Luo, Y., Xu, H. M., Zhang, X., Jiang, L., Xing, C. Z., and Zhang, Y. (2011) MicroRNA-148b is frequently down-regulated in gastric cancer and acts as a tumor suppressor by inhibiting cell proliferation. Mol. Cancer 10, 1
38. Gardino, A. K., and Yaffe, M. B. (2011) 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin. Cell Dev. Biol. 22, 688-695
39. Hermeking, H. (2003) The 14-3-3 cancer connection. Nat. Rev. Cancer 3, 931-943
40. Nomura, M., Shimizu, S., Sugiyama, T., Narita, M., Ito, T., Matsuda, H., and Tsujimoto, Y. (2003) 14-3-3 Interacts directly with and negatively regulates pro-apoptotic Bax. J. Biol. Chem. 278, 2058-2065
41. Zhao, J., Meyerkord, C. L., Du, Y., Khuri, F. R., and Fu, H. (2011) 14-3-3 proteins as potential therapeutic targets. Semin. Cell Dev. Biol. 22, 705-712
42. Cai, M. Y., Xu, Y. F., Qiu, S. J., Ju, M. J., Gao, Q., Li, Y. W., Zhang, B. H., Zhou, J., and Fan, J. (2009) Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection. Clin. Cancer Res. 15, 4686-4693
43. Diao, S., Zhang, J. F., Wang, H., He, M. L., Lin, M. C., Chen, Y., and Kung, H. F. (2010) Proteomic identification of microRNA-122a target proteins in hepatocellular carcinoma. Proteomics 10, 3723-3731
44. Liu, J., Valencia-Sanchez, M. A., Hannon, G. J., and Parker, R. (2005) MicroRNA-dependent localization of targeted mRNAs to mammalian Pbodies. Nat. Cell Biol. 7, 719-723
45. Morrison, D. K. (2009) The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 19, 16-23
46. Freeman, A. K., and Morrison, D. K. (2011) 14-3-3 Proteins: diverse functions in cell proliferation and cancer progression. Semin. Cell Dev. Biol. 22, 681-687
47. Obsil, T., and Obsilova, V. (2011) Structural basis of 14-3-3 protein functions. Semin. Cell Dev. Biol. 22, 663-672
48. Neal, C. L., and Yu, D. (2010) 14-3-3ζ as a prognostic marker and therapeutic target for cancer. Expert Opin. Ther. Targets 14, 1343-1354
49. Nishimura, Y., Komatsu, S., Ichikawa, D., Nagata, H., Hirajima, S., Takeshita, H., Kawaguchi, T., Arita, T., Konishi, H., Kashimoto, K., Shiozaki, A., Fujiwara, H., Okamoto, K., Tsuda, H., and Otsuji, E. (2013) Overexpression of YWHAZ relates to tumor cell proliferation and malignant outcome of gastric carcinoma. Br. J. Cancer 108, 1324-1331
50. Minamida, S., Iwamura, M., Kodera, Y., Kawashima, Y., Tabata, K., Matsumoto, K., Fujita, T., Satoh, T., Maeda, T., and Baba, S. (2011) 14-3-3 protein β/α as a urinary biomarker for renal cell carcinoma: proteomic analysis of cyst fluid. Anal. Bioanal. Chem. 401, 245-252
51. Braconi, C., Huang, N., and Patel, T. (2010) MicroRNA-dependent regulation ofDNAmethyltransferase-1 and tumor suppressor gene expression by interleukin-6 in human malignant cholangiocytes. Hepatology 51, 881-890
52. Bonelli, P., Tuccillo, F. M., Borrelli, A., Schiattarella, A., and Buonaguro, F. M. (2014) CDK/CCN and CDKI alterations for cancer prognosis and therapeutic predictivity. Biomed. Res. Int. 2014, 361020
53. Pavan, L., Tarrade, A., Hermouet, A., Delouis, C., Titeux, M., Vidaud, M., Thérond, P., Evain-Brion, D., and Fournier, T. (2003) Human invasive trophoblasts transformed with simian virus 40 provide a new tool to study the role of PPAR- in cell invasion process. Carcinogenesis 24, 1325-1336